Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome. [electronic resource]
Producer: 20190520Description: 379-389 p. digitalISSN:- 1476-5551
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- administration & dosage
- Benzimidazoles -- administration & dosage
- Cytarabine -- administration & dosage
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Leukemia, Myeloid, Acute -- diagnosis
- Male
- Middle Aged
- Myelodysplastic Syndromes -- diagnosis
- Phenylurea Compounds -- administration & dosage
- Prognosis
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.